By agata [dot] garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 26 January 2022 Head of Department Tomas Deierborg. Photo: Kennet Ruona ...showing that competitors in the Vasaloppet cross-country ski race run a lower risk of suffering from anxiety than the general population. Your results have been reported by the New York Times, CNN and many other international news outlets. P

https://www.medicine.lu.se/article/hello-professor-tomas-deierborg-and-congratulations-considerable-international-attention-attracted - 2025-03-27

By asa [dot] hansdotter [at] med [dot] lu [dot] se (Åsa Hansdotter) - published 3 February 2022 Immune Thrombocytopenia, ITP, is an autoimmune bleeding disorder that is still treated with immunosuppressive drugs that cause serious side effects. Professor John Semple’s laboratory studies the pathophysiological mechanisms behind this disease and together with Dr. Drew Provan, London, UK, has recentl

https://www.medicine.lu.se/article/new-therapies-itp - 2025-03-27

By agata [dot] garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 8 February 2022 Toxin-antitoxin pairs consist of a gene encoding a toxin that inhibits bacterial growth and an adjacent gene encoding an antitoxin that counteracts the toxic effect. It is like keeping a bottle of poison on a shelf next to a bottle of the antidote. Researchers in Lund have discovered an antitoxin me

https://www.medicine.lu.se/article/new-multipurpose-switch-inhibiting-bacterial-growth - 2025-03-27

By katrin [dot] stahl [at] med [dot] lu [dot] se (Katrin Ståhl) - published 28 February 2022 Image: iStock/Design Cells In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionised areas of cancer care. However, there are still signif

https://www.medicine.lu.se/article/new-precision-technology-immunotherapy - 2025-03-27

By katrin [dot] stahl [at] med [dot] lu [dot] se (Katrin Ståhl) - published 27 May 2020 From left: Lisa Påhlman, Nicholas Leigh and Andreas Edsfeldt. Three researchers joined the Wallenberg Centre for Molecular Medicine at Lund University (WCMM LU) during the spring. In total, there are now 24 research team leaders recruited to the WCMM at Lund University – 14 clinical researchers and 10 basic res

https://www.medicine.lu.se/article/three-new-researchers-wcmm - 2025-03-27

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 29 May 2020 Research published in the research journal Diabetologia needs to meet a high standard of quality. Most of the manuscripts submitted are rejected. At the start of 2021, Hindrik Mulder, MD and professor at Lund University Diabetes Centre (LUDC), will take over as editor-in-chief of the journal. After just over

https://www.medicine.lu.se/article/hindrik-mulder-incoming-editor-chief-diabetologia - 2025-03-27

By alexander [dot] doyle [at] med [dot] lu [dot] se (Alexander Doyle) - published 1 June 2020 Neuroblasts (green) in the aged brain traveling from the subventricular zone (SVZ) to the olfactory bulb (OB) via the rostral migratory stream (RMS). Proliferating cells are shown in red. Image from Jonas Fritze. Neurogenesis, the process by which new neurons are formed, dramatically declines in the aging

https://www.medicine.lu.se/article/researchers-identify-novel-regulator-neurogenesis-aged-brain - 2025-03-27

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 15 June 2020 Tomas Leanderson, Pofessor of Immunology, retires on July 1st. Photo: Agata Garpenlind A sun drenched day in the allies of Västra Hamnen. A whirlwind of black and white tails, snouts and barks are on duty at the townhouse door. Dog dad, Professor of Immunology Tomas Leanderson, hushes, admonishes, welc

https://www.medicine.lu.se/article/one-last-ones-out-old-school-professors - 2025-03-27

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 16 June 2020 Karl Swärd wants to find answers to how an elevated blood pressure damages the vessels. Photo. Agata Garpenlind High blood pressure damages our blood vessels. It also damages our heart, our brain and our kidneys. A high blood pressure increases the risk of suffering a heart attack and stroke. However,

https://www.medicine.lu.se/article/high-blood-pressure-bloody-serious - 2025-03-27

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 16 June 2020 Åsa Petersén works hard at i to find treatment that slows down Huntington's disease. A person who carries the mutant gene will at some point in his or her life develop the deadly Huntington's disease. This brain disease can be inherited from generation to generation and begins insidiously, making it in

https://www.medicine.lu.se/article/huntingtons-disease-fascinating-and-touching-mystery - 2025-03-27

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 16 June 2020 Gunilla Westergren-Thorsson wants to establish methods to identify risk groups at an early stage. Photo Agata Garpenlind. Pulmonary fibrosis is a severe and life shortening chronic condition. Although most people experience mild symptoms of COVID-19, some patients develop serious and life-threatening c

https://www.medicine.lu.se/article/identification-prognostic-markers-development-chronic-lung-fibrosis-covid-19-patients - 2025-03-27

By ">Sara Liedholm - published 22 June 2020 Paul Franks (Photo: Kennet Ruona) A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The report includes a detailed overview and roadmap for how this new approach to diabetes medicine can be evaluated and impleme

https://www.medicine.lu.se/article/roadmap-precision-medicine-diabetes-care - 2025-03-27

Published 24 June 2020 Adriana Sanna defended a thesis on 20 May, Shamik Mitra on 26 May and Rita Cabrita on 10 June. Adriana Sanna defended a thesis on 20 May, Shamik Mitra on 26 May and Rita Cabrita on 10 June. How come there were three at almost the same time?“All three were admitted simultaneously through MELGEN, a European network that has Marie Curie funding. My trio of doctoral students wer

https://www.medicine.lu.se/article/three-doctoral-thesis-defences-1-week - 2025-03-27

By alexander [dot] doyle [at] med [dot] lu [dot] se (Alexander Doyle) - published 25 June 2020 Postdoctoral researcher Agatheeswaran Subramaniam and PhD Student Kristijonas Žemaitis from the Stem Cell Regulators research group. Photo: Alexander Doyle Researchers from Lund Stem Cell Center have identified a novel target for the expansion of human blood stem cells ex vivo and shed light on the mecha

https://www.medicine.lu.se/article/new-insights-ex-vivo-expansion-transplantable-human-blood-stem-cells - 2025-03-27

By Agata [dot] Garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 25 June 2020 Dr. Yuriy Pomeshchik (left) and Dr. Laurent Roybon, lead and senior authors of the study. Photo: Agata Garpenlind Neuroscientists and stem cell researchers at Lund University in Sweden have developed a research model that allows studying human hippocampal neurons, the brain cells primarily affected by

https://www.medicine.lu.se/article/new-research-paves-way-developing-therapies-could-slow-down-alzheimers - 2025-03-27

Published 24 July 2020 Alex Evilevitch (Photo: Tove Smeds) Researchers at Lund University in Sweden have discovered a new method to treat human herpes viruses. The new broad-spectrum method targets physical properties in the genome of the virus rather than viral proteins, which have previously been targeted. The treatment consists of new molecules that penetrate the protein shell of the virus and

https://www.medicine.lu.se/article/antiviral-method-against-herpes-paves-way-combatting-incurable-viral-infections - 2025-03-27

Published 28 July 2020 A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive impairment, according to a large international study published today in the Journal of the American Medical Association (JAMA) and simu

https://www.medicine.lu.se/article/new-blood-test-shows-great-promise-diagnosis-alzheimers-disease - 2025-03-27

By agata [dot] garpenlind [at] med [dot] lu [dot] se (Agata Garpenlind) - published 5 August 2020 Illustration of the pH-responsive mesoporous silica nanoparticles designed to specifically target lung cancer. A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to sp

https://www.medicine.lu.se/article/new-promising-treatment-uses-smart-nanoparticles-target-lung-cancer - 2025-03-27

Published 18 August 2020 Around 20,000 people have been diagnosed with Parkinson's disease in Sweden. Today, there is no imaging method of changes in the brain that are believed to cause the disease. Researchers at Skåne University Hospital and Lund University have received nearly SEK 7 million from the Michael J Fox Foundation to develop an imaging technique that can more accurately detect and tr

https://www.medicine.lu.se/article/millions-michael-j-fox-foundation-improve-diagnosis-parkinsons - 2025-03-27

By Alexander [dot] doyle [at] med [dot] lu [dot] se (Alexander Doyle) - published 16 September 2020 Immunofluorescence image of human neurons derived from stem cells. Image credit: Agnete Kirkeby Prof. Johan Jakobsson and Assoc. Prof. Agnete Kirkeby from Lund Stem Cell Center and University of Copenhagen, along with co-applicants Prof. Roger Barker from Cambridge, UK and Assoc. Prof. Molly Hammell

https://www.medicine.lu.se/article/researchers-investigate-role-transposable-elements-neuroinflammation-and-parkinsons-disease - 2025-03-27